The temporal expression of transforming growth factor-beta(1) in early aortocoronary vein grafts

被引:6
|
作者
Dattilo, JB
Lust, RM
Dattilo, MPM
Parker, FM
Meadows, WM
Sun, YS
Chitwood, WR
Makhoul, RG
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV VASC SURG,RICHMOND,VA 23298
[2] E CAROLINA UNIV,SCH MED,DEPT SURG,GREENVILLE,NC 27858
关键词
FACTOR-BETA; INTIMAL HYPERPLASIA; CELLS; PROLIFERATION; MATRIX; GENE;
D O I
10.1006/jsre.1997.5076
中图分类号
R61 [外科手术学];
学科分类号
摘要
The success of coronary reconstructive procedures is limited by the high incidence of restenosis secondary to intimal hyperplasia (IH). Transforming growth factor-beta(1) (TGF-beta(1)) is a growth factor which has been shown to be important in the early development of IH in arteries and peripheral vein grafts. To date, there is little information concerning the early remodeling in aortocoronary vein grafts (ACVG). The purpose of this study was to characterize the expression of TGF-beta(1), expression in early aortocoronary vein grafts. Eighteen mongrel dogs underwent aortocoronary vein bypass grafting. Vein grafts were excised at 2 hr, 4 hr, and 7 days after implantation, snap frozen, and processed for ribonuclease protection assays (RPA) using P-32-labeled riboprobes for TGF-beta(1) and 18 S rRNA. TGF-beta(1) expression was quantified by densitometric analysis of autoradiographs which were expressed as a ratio TGF-beta(1)/rRNA. Representative vessel rings were also collected for histology, There was a significant rise in TGF-beta(1) expression in the 2-hr vein grafts (0.42 +/- 0.04 compared to control saphenous vein 0.21 +/- 0.05, P < 0.02). In addition, there was significant downregulation of TGF-beta(1) at 4 hr (0.28 +/- 0.05) and at 7 days (0.18 +/- 0.01) when compared to 2 hr (P < 0.05). Histological specimens showed minimal intimal hyperplasia at 7 days. These results show for the first time an acute rise in TGF-beta(1) expression in ACVG. This upregulation quickly subsides by 4 hr and gene expression approaches control values by 7 days, By understanding this temporal relationship of expression one could better target potential therapeutic modalities to attenuate IH. (C) 1997 Academic Press.
引用
收藏
页码:349 / 353
页数:5
相关论文
共 50 条
  • [21] Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin
    Teicher, BA
    Maehara, Y
    Kakeji, Y
    Ara, G
    Keyes, SR
    Wong, J
    Herbst, R
    INTERNATIONAL JOURNAL OF CANCER, 1997, 71 (01) : 49 - 58
  • [22] Uncoordinated regulation of mRNA expression of the three isoforms of transforming growth factor-beta in the mouse skin carcinogenesis model
    Rundhaug, JE
    Park, J
    Fischer, SM
    MOLECULAR CARCINOGENESIS, 1997, 18 (02) : 115 - 126
  • [23] Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-beta 1 and -beta 2 expression may explain metaplastic bone formation
    Teot, LA
    OKeefe, RJ
    Rosier, RN
    OConnell, JX
    Fox, EJ
    Hicks, DG
    HUMAN PATHOLOGY, 1996, 27 (07) : 625 - 632
  • [24] Transforming growth factor-beta increases breast cancer stem cell population partially through upregulating PMEPA1 expression
    Nie, Zhi
    Wang, Chunyan
    Zhou, Zhongmei
    Chen, Ceshi
    Liu, Rong
    Wang, Dianhua
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (02) : 194 - 201
  • [25] Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment
    Lindstrom, P
    Bergh, A
    Holm, I
    Damber, JE
    PROSTATE, 1996, 29 (04) : 209 - 218
  • [26] Prognostic Relevance of Transforming Growth Factor-beta Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype
    Togni, Claudio
    Rom, Emanuel
    Burghardt, Isabel
    Roth, Patrick
    Rushing, Elisabeth J.
    Weller, Michael
    Gramatzki, Dorothee
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2022, 81 (03) : 225 - 235
  • [27] Transforming Growth Factor Beta 1 Regulates Fibroblast Growth Factor 7 Expression in Schwann Cells
    Doan Nguyen
    Sulaiman, Olawale A. R.
    OCHSNER JOURNAL, 2019, 19 (01) : 7 - 12
  • [28] Platelet-Derived Growth Factor-BB Couples with Transforming Growth Factor-Beta 1 to Make a Potential for Bone Engineering
    Wang, Zong-Jiang
    Mu, Wei-Dong
    Yang, Ling-Ling
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2018, 8 (05) : 678 - 683
  • [29] Examining potential therapies targeting myocardial fibrosis through the inhibition of transforming growth factor-beta 1
    Khan, Razi
    CARDIOLOGY, 2007, 108 (04) : 368 - 380
  • [30] Suppressing role of transforming growth factor-beta 1 on cathepsin activity in cultured kidney tubule cells
    Ling, H
    Vamvakas, S
    Busch, G
    Dammrich, J
    Schramm, L
    Lang, F
    Heidland, A
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 269 (06): : F911 - F917